Novo Nordisk and Karolinska Institutet signed a collaboration agreement on Monday that will create an international post-doctoral fellowship program in the field of diabetes.
Fully funded by Novo Nordisk, the program will provide 12 post-doctoral researchers three-year grants to complete their research within the area of diabetes and metabolism.
The research will be conducted at the Karolinska Institutet in Stockholm, Sweden. There is also the possibility of a research exchange program at Novo Nordisk Research and Development in Denmark.
The program provides a chance to recruit young diabetes researchers to the Karolinska Institutet, Anders Hamsten, vice-chancellor at Karolinska Institutet, said. A joint steering committee, made up of members from both organizations, will oversee the program and be responsible for recruiting researchers. The first four fellows are expected to begin in the fall.
"Together, we will train scientists in exploring basic diabetes research and translating this into new potential treatments for patients,” Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk, said. “Building upon the unique academic and clinical tradition at Karolinska Institutet and our company's excellence in research and development, the collaboration holds great potential to stimulate innovation and ultimately to improve the lives of the patients."
Alerts Sign-up